COGNITIVE DEBRIEFING OF THE ADVANCED SYSTEMIC MASTOCYTOSIS SYMPTOM ASSESSMENT FORM (ADVSM-SAF)

被引：0
|
作者：
Taylor, F. [1 ]
Kreil, S. [2 ]
Reiter, A. [2 ]
Horny, H. [3 ]
Evans, E. [4 ]
Mazar, I [1 ]
McNamara, P. [4 ]
Boral, A. [4 ]
Lamoureux, R. E. [1 ]
Shields, A. [1 ]
Gotlib, J. [5 ]
机构：
[1] Adelphi Values, Boston, MA USA
[2] Univ Hosp Mannheim, Mannheim, Germany
[3] Ludwig Maximilians Univ Munchen, Munich, Germany
[4] Blueprint Med, Cambridge, MA USA
[5] Stanford Canc Ctr, Stanford, CA USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRM136
引用
收藏
页码：A335 / A336
页数：2
相关论文
共 42 条
  • [31] The Myleloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Derived Total Symptom Score (TSS): An International Trial of 1433 Patients with Myeloproliferative Neoplasms (MPNs)
    Scherber, Robyn
    Dueck, Amylou
    Kiladjian, Jean-Jacques
    Slot, Stephanie
    Zweegman, Sonja
    Boekhorst, Peter Te
    Commandeur, Suzan
    Schouten, Harry C.
    Sackmann, Federico
    Fuentes, Ana Kerguelen
    Hernandez-Maraver, Dolores
    Pahl, Heike L.
    Griesshammer, Martin
    Stegelmann, Frank
    Doehner, Konstanze
    Lehmann, Thomas
    Bonatz, Karin
    Reiter, Andreas
    Boyer, Francoise
    Etienne, Gabriel
    Ianotto, Jean-Christophe
    Ranta, Dana
    Roy, Lydia
    Cahn, Jean-Yves
    Harrison, Claire N.
    Radia, Deepti
    Muxi, Pablo J.
    Maldonado, Norman I.
    Besses, Carlos
    Cervantes, Francisco
    Johansson, Peter
    Barbui, Tiziano
    Barosi, Giovanni
    Vannucchi, Alessandro M.
    Passamonti, Francesco
    Andreasson, Bjorn
    Ferarri, Maria L.
    Rambaldi, Alessandro
    Samuelsson, Jan
    Birgegard, Gunnar
    Tefferi, Ayalew
    Mesa, Ruben A.
    BLOOD, 2011, 118 (21) : 1640 - 1641
  • [32] USING MYELOPROLIFERATIVE NEOPLASM SYMPTOM ASSESSMENT FORM (MPN-SAF) TO EVALUATE QUALITY OF LIFE FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA IN QATAR
    Yassin, M.
    Elayoubi, H.
    Kamzoul, R.
    Eldewik, N.
    HAEMATOLOGICA, 2013, 98 : 623 - 623
  • [33] A Snapshot Audit of Symptom Burden in Patients with Indolent Systemic Mastocytosis Utilising the ISM-SAF © within a UK Centre of Excellence: Guy's and St Thomas' NHS Foundation Trust
    Veitch, Scott
    Asirvatham, Susan
    Sriskandarajah, Priya
    Saha, Chandan
    Oni, Clare
    Grattan, Clive
    Radia, Deepti H.
    BLOOD, 2023, 142
  • [34] Translation, Cultural Adaptation, and Validation into Romanian of the Myeloproliferative Neoplasm Symptom Assessment Form-Total Symptom Score (MPN-SAF TSS or MPN-10) Questionnaire
    Gaman, Mihnea-Alexandru
    Scherber, Robyn Marie
    Ursuleac, Iulia
    Crisan, Ana Manuela
    Badelita, Sorina Nicoleta
    Ionescu, Bogdan Octavian
    Ghiaur, Alexandra Elena
    Brinza, Melen
    Pirciulescu, Nicoleta
    Lascar, Toma Octavian
    Diaconu, Camelia Cristina
    Gaman, Amelia Maria
    Coriu, Daniel
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [35] Validity of the Memorial Symptom Assessment Scale-Short Form Psychological Subscales in Advanced Cancer Patients
    Webber, Katherine
    Davies, Andrew N.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2011, 42 (05) : 761 - 767
  • [36] Preliminary Safety and Efficacy from Apex, a Phase 2 Study of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Adults with Advanced Systemic Mastocytosis (AdvSM)
    DeAngelo, Daniel J.
    Pullarkat, Vinod A.
    Piris-Villaespesa, Miguel
    George, Tracy, I
    Patel, Jay L.
    Ustun, Celalettin
    Bose, Prithviraj
    Heaney, Mark L.
    Sachs, Jessica
    Sun, Lei
    Pilla, Amanda
    Exter, Benjamin
    Jolin, Hina A.
    Tashi, Tsewang
    BLOOD, 2022, 140 : 1512 - 1513
  • [37] Safety and Efficacy of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis (AdvSM): Results From Part 1 of the Phase 2 Apex Trial
    Vachhani, Pankit
    Tashi, Tsewang
    Schiller, Gary
    Lee, Stephanie
    Piris-Villaespesa, Miguel
    Pomares, Helena
    Livideanu, Cristina Bulai
    Lambert, Jonathan
    Hunter, Anthony M.
    George, Tracy I.
    Patel, Jay
    DeAngelo, Daniel J.
    Papayannidis, Cristina
    Shoumariyeh, Khalid
    Exter, Ben
    Sun, Lei
    Zhang, Jenna
    Cable, LouAnn
    Pilla, Amanda
    Jolin, Hina A.
    Easton, Rachael
    Carden, Marcus
    Pullarkat, Vinod
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S429 - S430
  • [38] Validation of the Serial Use of the Myelofibrosis Symptom Assessment Form (MF-SAF) for Measuring Symptomatic Improvement: Performance in 86 Myelofibrosis Patients On INCB018424 Clinical Trial.
    Mesa, Ruben A.
    Kantarjian, Hagop
    Tefferi, Ayalew
    Levy, Richard
    Vaddi, Kris
    Erickson-Viitanen, Susan
    Thomas, Deborah A.
    Cortes-Franco, Jorge
    Borthakur, Gautam
    Pardanani, Animesh D.
    Estrov, Zeev
    Verstovsek, Srdan
    BLOOD, 2009, 114 (22) : 1506 - 1507
  • [39] Comparison of the Myleloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Across Nine Linguistic Translations Among an International Sample of 1,851 Myeloproliferative Neoplasm (MPN) Patients
    Dueck, Amylou Constance
    Emanuel, Robyn M.
    Geyer, Holly Lynn
    Kiladjian, Jean-Jacques
    Slot, Stephanie
    Zweegman, Sonja
    Boekhorst, Peter Te
    Commandeur, Suzan
    Schouten, Harry C.
    Sackmann, Federico
    Kerguelen Fuentes, Ana
    Hernandez, Dolores
    Pahl, Heike L.
    Griesshammer, Martin
    Stegelmann, Frank
    Doehner, Konstanze
    Lehmann, Thomas
    Bonatz, Karin
    Reiter, Andreas
    Boyer, Franoise
    Etienne, Gabriel
    Ianotto, Jean-Christophe
    Ranta, Dana
    Roy, Lydia
    Cahn, Jean-Yves
    Harrison, Claire N.
    Radia, Deepti H.
    Muxi, Pablo J.
    Maldonado, Norman I.
    Besses, Carlos
    Cervantes, Francisco
    Johansson, Peter
    Barbui, Tiziano
    Barosi, Giovanni
    Vannucchi, Alessandro M.
    Passamonti, Francesco
    Andreasson, Bjorn
    Ferarri, Maria L.
    Rambaldi, Alessandro
    Samuelsson, Jan
    Birgegard, Gunnar
    Tefferi, Ayalew
    Xiao, Zhijian
    Xu, Zefeng
    Zhang, Yue
    Sun, Xiujuan
    Xu, Junqing
    Zhang, Peihong
    Gale, Robert Peter
    Mesa, Ruben A.
    BLOOD, 2012, 120 (21)
  • [40] Safety and Efficacy of Bezuclastinib ( CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (AdvSM): Results from Part 1 of the Phase 2 Apex Trial
    Vachhani, Pankit
    Tashi, Tsewang
    Schiller, Gary J.
    Lee, Stephanie
    Villaespesa, Miguel Piris
    Pomares, Helena
    Livideanu, Cristina Bulai
    Lambert, Jonathan
    Hunter, Anthony M.
    George, Tracy I.
    Papayannidis, Cristina
    Shoumariyeh, Khalid
    Petroro, Rita
    Zhang, Jenna
    Pilla, Amanda
    Jolin, Hina
    Easton, Rachael
    Pullarkat, Vinod
    BLOOD, 2023, 142
12345